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BLOOD SERUM TO DIAGNOSE OSTEOARTHRITIS – BIOMARKERS AND
MACHINE LEARNING
B.J. Heard, J.M. Rosvold, M.J. Fritzler, H. El-Gabalawy, J.P. Wiley,
R.J. Krawetz. Univ. of Calgary, Calgary, AB, Canada
Purpose: Although reliable diagnostics for rheumatoid arthritis (RA)
exist, currently only relatively advanced osteoarthritis (OA) can be
clinically diagnosed with high conﬁdence using a combination of
physical exam / functional assessment with radiographic evidence of
OA related structural changes (e.g. joint space narrowing, osteophytes).
The objective of this study was to develop a method for categorizing
patients with OA and RA, as well as discriminating both groups from
normal individuals based on a panel of inﬂammatory cytokines
expressed in blood serum samples.
Methods: Inclusion criteria required a diagnosis of mild/moderate OA
performed by a sports medicine physician at the University of Calgary
based on clinical symptoms for  3 months with radiographic evidence
of changes associated with OA. Inclusion for RA patients required
physician diagnosis (autonuclear antibody positive). RA patients were
all receiving various anti-inﬂammatory treatments at the time serum
was sampled. Normal control individuals were disqualiﬁed if any per-
sonal or family history of arthritis or autoimmune diseases were dis-
closed (e.g. systemic lupus erythematosus, sclero- derma, polymyositis,
vasculitis, spondyloarthropathies, inﬂammatory bowel disease, dia-
betesmellitus type I, and/or thyroid disease). Blood serumwas collected
and a panel of 38 inﬂammatory proteins was quantiﬁed using Luminx
Multiplexing. This panel was then used as a training set in the con-
struction of an artiﬁcial neural network (ANN) (Matlab – ANN toolbox)
to indentify patients with OA (n ¼ 100), RA (n ¼ 100), and normal
individuals (n ¼ 100). The results for the ANN were veriﬁed by reex-
amining the data using a decision tree algorithm (Matlab – Treebagger
Algorithm).
Results: High levels of sensitivity and speciﬁcity were obtained within
the ANN using all 38 cytokines (sensitivity/speciﬁcity – Norm: 100/100,
OA: 100/100, RA: 100/100). These results were veriﬁed through the
reinvestigation of the data set using a decision tree algorithm that
returned a similar sensitivity/speciﬁcity (Norm: 100/96, OA: 100/97, RA:
95/100). Results have been summarized in Table 1, this table shows a
summary of the ANN (right) training, validation, and test sets, as well as
the decision tree (left) training, test, and all data sets. Data is presented
as the number of patients allocated by patient type on the left, and the
diagnosis (categorization by the algorithm) on the top.
Conclusion: Using the panel of 38 cytokines, we were able to train an
ANN to distinguish between our 3 patient groups with a high degree of
sensitivity and speciﬁcity. These results were veriﬁed using a decision
tree algorithm. Joint imaging techniques are improving in the diagnosis
of OA, but the need still exists for a reliable non-invasive diagnostic tool
to at least support an early and accurate diagnosis. Through the use of a
panel of well documented inﬂammatory cytokines, we have developed
a non-invasive test that can be used to identify patients with OA of the
knee. Although there is currently no disease modifying treatment for
early OA, however, the panel of cytokines that we have developed may
prove useful for the development and evaluation of futureTable 1
ANN and decision tree summaries
ANN: All Cytokines (n¼38) Treebagger: All Cytokines (n¼38)
Diagnosis Diagnosis
Normal OA RA Normal OA RA
Training Set Training Set
Patient Type Normal 75 0 0 76 0 0
OA 1 66 0 0 71 0
RA 1 0 67 0 0 63
Validation Set Test set
Patient Type Normal 11 0 0 24 0 0
OA 0 21 0 0 29 0
RA 0 0 13 1 1 35
Test Set All Data
Patient Type Normal 12 0 0 100 0 0
OA 0 13 0 0 100 0
RA 0 0 20 1 1 98pharmacological or even surgical interventions. Osteoarthritis is a
complex disease with a complex phenotype, to account for hetero-
geneity of a patient population in addition to heterogeneity of a disease
state (e.g. onset, pathogenesis and progression) an effective diagnoses
will likely require a relatively complex interpretation of data.
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INCREASED ADIPOSITY IN RESPONSE TO HIGH FAT/HIGH SUCROSE
DIET IS ASSOCIATED WITH INCREASED CONCENTRATIONS OF
CYTOKINES AND ADIPOKINES IN SYNOVIAL FLUID
K.H. Collins, R.A. Reimer, W. Herzog. Univ. of Calgary, Calgary, AB,
Canada
Obesity is associated with chronic inﬂammation. The increased inci-
dence of Osteoarthritis (OA) in obese individuals has been attributed to
increases in mechanical joint load. However, a distinct subtype of OA
may be the result of other intrinsic factors related to adiposity. There-
fore this so-called “metabolic” OA displays a unique disease trajectory,
potentially independent of joint loading. Sprague Dawley rats display
diet-induced obesity prone (DIO-P) and obesity resistant (DIO-R) phe-
notypes, providing the opportunity to evaluate increased adiposity
when mass is conserved.
Purpose: The purpose of this study was to compare the joint damage
and synovial ﬂuid (SF) biomarkers from DIO-P and DIO-R rats after six
months of high fat diet.
Methods: Fourteen male, 8-12 week old Sprague-Dawley rats were
given a high fat diet (40% fat) for 12 weeks, at which point the top 50%
percent of weight gainers (based on % change in mass over 12 week
obesity induction) were labeled DIO-P and the bottom 50% were
labeled DIO-R. Rats were followed for an additional 16 weeks con-
tinuing the same high fat diet. At sacriﬁce, body composition (% body
fat, BF) was measured using Dual Energy X-ray Absorptiometry.
Twenty seven serum and SF cytokines and adipokines were quantiﬁed
using a LuminexxMAP Rat 27 Multiplex Discovery Assay, and urea
was quantiﬁed in both serum and SF using an ELISA (Eve Technologies,
Calgary, AB). SF and serum concentration of urea was used to adjust for
differences in SF concentration. Joints were harvested and scored on a
14-point Mankin scale in ﬁve regions along the joint (medial tibial
plateau, lateral tibial plateau, medial femoral condyle, lateral femoral
condyle, and patella). Subchondral bone and synovium were assessed
using each respective (5- and 6- point) criteria from the rat OARSI
metric. A Modiﬁed Mankin composite score was determined by adding
the 7 scores to provide a volumetric quantiﬁcation of damage. Kruskal-
Wallis tests and Pearson correlations were used to evaluate Modiﬁed
Mankin Composite scores, and to associate SF and serum cytokines by
obesity response (a ¼ 0.1).
Results: Body Mass was not different between the groups (DIO-P¼ 729
 43g DIO-R¼ 792  48g, p ¼ 0.18). Percentage body fat was higher in
DIO-P (41.8  2.4%,) compared with DIO-R (32.5  0.8%,p ¼ 0.002). OA
scores were higher in DIO-P (DIO-P mean¼ 27, 95% CI (17-37), DIO-R
mean¼ 18, 95% CI 8-30, p¼ 0.09). DIO-P OA scores were associated with
body fat percentage (r¼ .81, p ¼ 0.02), and 6 SF markers: leptin (r ¼ .68,
p¼ 0.08), IL-5 (r¼ 0.63, p¼ 0.09), IL-18 (r¼ .74, p¼ 0.03) IP10/CXCL10 (r
¼ .74, p ¼ 0.02), VEGF (r ¼ .74, p ¼ 0.03) and RANTES/CCL5 (r ¼ .72, p ¼
0.04). Serum markers associated with DIO-P OA scores include: IL-1b (r
¼ 0.744, p¼ 0.03), IL-10 (r¼ .66, p¼ 0.07), IP10/CXCL10 (.844, p¼ 0.01).
IP10/CXCL10 serum concentration was strongly associated with IP10/
CXCL10 SF concentration (r ¼ .78, p ¼ 0.02), but neither Il-10 nor IL-1b
serum was associated with their respective SF concentration. None of
the measured serum or SF markers were associated with OA score in
DIO-R animals.
Conclusion: DIO-P animals had increased joint damage compared to
DIO-R. Increased adiposity is associated with increased Modiﬁed
Mankin Composite score in DIO-P animals. Body fat and six pro-
inﬂammatory cytokine SF concentrations were associated with OA
damage in DIO-P animals. Most notably, IP10/CXCL10 (Interferon-
gamma inducible protein 10) is associated with joint damage in both SF
and serum concentrations, and there is a strong relationship between
SF and serum concentration of this chemokine. IP10/CXCL10 is a chemo-
attractant for monocytes and macrophages, selectively activated by
leptin, which has been implicated in cartilage damage. IP10/CXCL10 is
associated with angiogenesis, and subcutaneous injection of this che-
mokine demonstrates increased inﬁltration of monocytes in fat and
muscle. Further investigation is needed to understand the role of IP10/
CXCL10 in metabolic OA.
